1. Home
  2. EVAX
  3. EVAX News

Latest Evaxion Biotech (EVAX) News on February 23, 2025

Nasdaq confirms Evaxion is fully compliant, withdraws delisting determination
EVAX

GlobeNewswire

9 days ago

Nasdaq confirms Evaxion is fully compliant, withdraws delisting determination

Evaxion Biotech price target lowered to $6 from $35 at Lake Street
EVAX

TipRanks

18 days ago

Evaxion Biotech price target lowered to $6 from $35 at Lake Street

EVAX

Zacks Small Cap Research

18 days ago

EVAX Ups Cash to Further Research

EVAX

MT Newswires

19 days ago

Top Premarket Gainers

Evaxion announces closing of $10.8 million public offering
EVAX

GlobeNewswire

23 days ago

Evaxion announces closing of $10.8 million public offering

Evaxion announces pricing of $10.8 million public offering
EVAX

GlobeNewswire

24 days ago

Evaxion announces pricing of $10.8 million public offering

Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement
EVAX

GlobeNewswire

a month ago

Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement

Evaxion concludes subject dosing in Phase II trial of melanoma vaccine
EVAX

Clinical Trials Arena

a month ago

Evaxion concludes subject dosing in Phase II trial of melanoma vaccine

Evaxion completes dosing in phase 2 trial with personalized cancer vaccine EVX-01
EVAX

GlobeNewswire

a month ago

Evaxion completes dosing in phase 2 trial with personalized cancer vaccine EVX-01

EVAX

Zacks Small Cap Research

a month ago

EVAX Adjusts Share Ratio

Evaxion announces completion of ADS ratio change
EVAX

GlobeNewswire

a month ago

Evaxion announces completion of ADS ratio change

Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change
EVAX

GlobeNewswire

a month ago

Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change

Evaxion announces plan to implement ADS ratio change
EVAX

GlobeNewswire

2 months ago

Evaxion announces plan to implement ADS ratio change

Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity
EVAX

GlobeNewswire

2 months ago

Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity

Evaxion establishes new AI-derived precision cancer vaccine concept
EVAX

GlobeNewswire

2 months ago

Evaxion establishes new AI-derived precision cancer vaccine concept

Evaxion announces 2025 milestones reflecting continued strong strategy execution
EVAX

GlobeNewswire

2 months ago

Evaxion announces 2025 milestones reflecting continued strong strategy execution

Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress
EVAX

GlobeNewswire

3 months ago

Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress

Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing
EVAX

GlobeNewswire

3 months ago

Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing

EVAX

Zacks Small Cap Research

3 months ago

EVAX Racks up Positive Test Results

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1
EVAX

GlobeNewswire

3 months ago

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1

Evaxion announces business update and third quarter 2024 financial results
EVAX

GlobeNewswire

4 months ago

Evaxion announces business update and third quarter 2024 financial results

EVAX

Zacks Small Cap Research

4 months ago

EVAX Exceeds Estimates and Confirms Partnership

Evaxion to announce business update and third quarter 2024 financial results on October 31
EVAX

GlobeNewswire

4 months ago

Evaxion to announce business update and third quarter 2024 financial results on October 31

EVAX

Zacks Small Cap Research

4 months ago

OTC Markets Hosts Virtual Investor Presentation with Christian Kanstrup, CEO of Evaxion Biotech, and Brad Sorensen, Senior Analyst at Zacks SCR

Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials
EVAX

GlobeNewswire

4 months ago

Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials

Evaxion Biotech Charts Future with Innovative Immune Therapies
EVAX

TipRanks

5 months ago

Evaxion Biotech Charts Future with Innovative Immune Therapies

EVAX

Zacks Small Cap Research

5 months ago

AI from EVAX Improves Trial Results

Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform
EVAX

GlobeNewswire

5 months ago

Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform

EVAX

MT Newswires

5 months ago

Evaxion Biotech Grants Merck Option to License Vaccine Candidates

Evaxion significantly expands vaccine development collaboration with MSD
EVAX

GlobeNewswire

5 months ago

Evaxion significantly expands vaccine development collaboration with MSD

EVAX

Zacks Small Cap Research

5 months ago

EVAX Process Continues to Garner Interest and Investment

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
EVAX

GlobeNewswire

5 months ago

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction
EVAX

GlobeNewswire

5 months ago

Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction

Life Sciences Virtual Investor Forum Agenda Announced for September 19th
EVAX

GlobeNewswire

5 months ago

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

Evaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-01
EVAX

GlobeNewswire

5 months ago

Evaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-01

Evaxion reports 69% Overall Response Rate in its phase 2 trial on lead cancer vaccine candidate EVX-01
EVAX

GlobeNewswire

5 months ago

Evaxion reports 69% Overall Response Rate in its phase 2 trial on lead cancer vaccine candidate EVX-01

Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2
EVAX

GlobeNewswire

5 months ago

Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2

EVAX

Zacks Small Cap Research

5 months ago

EVAX Uses AI Platform to Generate Positive Treatment Data

Evaxion Biotech A/S (NASDAQ:EVAX): Is Breakeven Near?
EVAX

Simply Wall St.

6 months ago

Evaxion Biotech A/S (NASDAQ:EVAX): Is Breakeven Near?

EVAX

Zacks Small Cap Research

6 months ago

EVAX is a Clinical Stage AI Company Worth a Look

Evaxion Announces Business Update and Second Quarter 2024 Financial Results
EVAX

GlobeNewswire

6 months ago

Evaxion Announces Business Update and Second Quarter 2024 Financial Results

Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14
EVAX

GlobeNewswire

6 months ago

Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14

Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September
EVAX

GlobeNewswire

6 months ago

Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September

EVAX

Zacks Small Cap Research

7 months ago

EVAX: Initiating Coverage of Evaxion

Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference
EVAX

GlobeNewswire

7 months ago

Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference

Evaxion Reinforces Milestone Timeline and Provides Shareholder Update
EVAX

GlobeNewswire

8 months ago

Evaxion Reinforces Milestone Timeline and Provides Shareholder Update

Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method
EVAX

GlobeNewswire

8 months ago

Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method

Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal
EVAX

GlobeNewswire

8 months ago

Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal

Here's Why Evaxion Biotecch (EVAX) Is a Great 'Buy the Bottom' Stock Now
EVAX

Zacks

8 months ago

Here's Why Evaxion Biotecch (EVAX) Is a Great 'Buy the Bottom' Stock Now

Lotto 6/49 - $64 million up for grabs in the next draw!
EVAX

CNW Group

8 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
EVAX

Simply Wall St.

8 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
EVAX

AFP

8 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
EVAX

Simply Wall St.

8 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
EVAX

Simply Wall St.

8 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
EVAX

Barrons.com

8 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
EVAX

Simply Wall St.

8 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
EVAX

Simply Wall St.

8 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024
EVAX

GlobeNewswire

9 months ago

Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024

Evaxion Announces Business Update and First Quarter 2024 Financial Results
EVAX

GlobeNewswire

9 months ago

Evaxion Announces Business Update and First Quarter 2024 Financial Results

EVAX

MT Newswires

9 months ago

Evaxion Biotech Plans to Unveil 'Positive' Data From Phase 2 Study of Advanced Melanoma Combination Treatment

Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024
EVAX

GlobeNewswire

9 months ago

Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024

Evaxion Receives Nasdaq Notification
EVAX

GlobeNewswire

9 months ago

Evaxion Receives Nasdaq Notification

Sidoti Events, LLC's Virtual May Micro-Cap Conference
EVAX

ACCESSWIRE

10 months ago

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01
EVAX

GlobeNewswire

10 months ago

Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01

Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data
EVAX

Zacks

a year ago

Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data

Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call Transcript
EVAX

Insider Monkey

a year ago

Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call Transcript

Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
EVAX

GlobeNewswire

a year ago

Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection

Evaxion Announces Business Update and Full Year 2023 Financial Results
EVAX

GlobeNewswire

a year ago

Evaxion Announces Business Update and Full Year 2023 Financial Results

When Will Evaxion Biotech A/S (NASDAQ:EVAX) Turn A Profit?
EVAX

Simply Wall St.

a year ago

When Will Evaxion Biotech A/S (NASDAQ:EVAX) Turn A Profit?

Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
EVAX

GlobeNewswire

a year ago

Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform

Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations
EVAX

GlobeNewswire

a year ago

Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations

Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
EVAX

GlobeNewswire

a year ago

Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD

Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement
EVAX

GlobeNewswire

a year ago

Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement

Evaxion Announces Closing of $15 Million Public Offering
EVAX

GlobeNewswire

a year ago

Evaxion Announces Closing of $15 Million Public Offering

Evaxion Biotech Announces Pricing of $15 Million Public Offering
EVAX

GlobeNewswire

a year ago

Evaxion Biotech Announces Pricing of $15 Million Public Offering

Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
EVAX

GlobeNewswire

a year ago

Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets

Western New England Bancorp, Inc. Reports Results for Three Months and Year Ended December 31, 2023 and Declares Quarterly Cash Dividend
EVAX

GlobeNewswire

a year ago

Western New England Bancorp, Inc. Reports Results for Three Months and Year Ended December 31, 2023 and Declares Quarterly Cash Dividend

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010
EVAX

GlobeNewswire

a year ago

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

Evaxion Announces Completion of ADS Ratio Change
EVAX

GlobeNewswire

a year ago

Evaxion Announces Completion of ADS Ratio Change

EVAX

Business Wire

a year ago

TransAct Announces BOHA! Solutions Order from Regional Assisted Living Communities

EVAX

Zacks Small Cap Research

a year ago

CTSO: CytoSorbents reports update on data results from important U.S. and Canadian STAR-T pivotal trial.

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
EVAX

GlobeNewswire

a year ago

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

Evaxion Announces Plan to Implement ADS Ratio Change
EVAX

GlobeNewswire

a year ago

Evaxion Announces Plan to Implement ADS Ratio Change

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event
EVAX

Business Wire

a year ago

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

Forian Inc. (NASDAQ:FORA) insiders have recently purchased stock and their bets paid off last week as company hit US$112m market cap
EVAX

Simply Wall St.

a year ago

Forian Inc. (NASDAQ:FORA) insiders have recently purchased stock and their bets paid off last week as company hit US$112m market cap

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
EVAX

GlobeNewswire

a year ago

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results
EVAX

PR Newswire

a year ago

Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results

Evaxion Biotech Announces Closing of Private Placement
EVAX

GlobeNewswire

a year ago

Evaxion Biotech Announces Closing of Private Placement

Evaxion Announces Business Update and Third Quarter 2023 Financial Results
EVAX

GlobeNewswire

a year ago

Evaxion Announces Business Update and Third Quarter 2023 Financial Results

Evaxion Biotech Announces Private Placement Financing
EVAX

GlobeNewswire

a year ago

Evaxion Biotech Announces Private Placement Financing

Insider Spends US$100k Buying More Shares In Cytosorbents
EVAX

Simply Wall St.

a year ago

Insider Spends US$100k Buying More Shares In Cytosorbents

Insider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)
EVAX

GuruFocus.com

a year ago

Insider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
EVAX

GlobeNewswire

a year ago

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

Greenland Technologies to Present at Water Tower Research Investor Conference
EVAX

PR Newswire

a year ago

Greenland Technologies to Present at Water Tower Research Investor Conference

LightPath Announces Initial $4.7m Order from Lockheed Martin
EVAX

ACCESSWIRE

a year ago

LightPath Announces Initial $4.7m Order from Lockheed Martin

LightPath Technologies Schedules Annual Meeting of Stockholders
EVAX

ACCESSWIRE

a year ago

LightPath Technologies Schedules Annual Meeting of Stockholders

Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant
EVAX

ACCESSWIRE

a year ago

Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept
EVAX

GlobeNewswire

a year ago

Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept

Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference
EVAX

GlobeNewswire

a year ago

Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference

LightPath Technologies Postpones Annual Meeting of Stockholders
EVAX

ACCESSWIRE

a year ago

LightPath Technologies Postpones Annual Meeting of Stockholders

Share on Social Networks: